Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
J FuX Liu

Abstract

Substance P (SP) is an important neurotransmitter and is an important pathogenic factor in obesity. However, the relationships between the inflammatory cytokines interleukin-6 (IL-6), C reactive protein (CRP) and SP with obesity and type 2 diabetes mellitus (T2DM) are poorly understood. We investigated the associations between SP, IL-6 and CRP with obesity and T2DM. The subjects comprised patients who underwent physical examinations at the First Affiliated Hospital of Harbin Medical University between January 2006 and December 2008. Overall, 156 subjects participated in this study, including 63 obese (BMI >25 kg/m²) subjects with T2DM, and 58 obese and 35 lean subjects without T2DM. Patient characteristics were collected from a health questionnaire form. Anthropometric measurements and fasting blood samples were assessed. SP, CRP, IL-6 and HOMA-IR were converted into log values. SP, IL-6, CRP and HOMA-IR were significantly higher ( P<0.05) in obese T2DM subjects compared with obese and lean subjects without T2DM. All 3 parameters were significantly associated with other risk factors for diabetes, including BMI, blood pressure, plasma glucose and high-density lipoprotein levels. After adjusting for age, SP was significantly and ...Continue Reading

Citations

Dec 12, 2013·Archives of Medical Research·Fernando Guerrero-RomeroMartha Rodríguez-Morán
Dec 1, 2014·Pathology, Research and Practice·Riffat MehboobFridoon Jawad Ahmad
Aug 16, 2016·Nutrition Research Reviews·Magdalena MucCristina Padez
Dec 22, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Pierre MiegueuKatherine Cianflone
Jan 21, 2017·Scandinavian Journal of Medicine & Science in Sports·P P Y Lui
Aug 5, 2017·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C A MaguireV M Navarro
Jun 29, 2021·Frontiers in Neurology·Eduardo Rivera-MancillaAntoinette MaassenVanDenBrink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.